Literature DB >> 28510124

Computer-aided estimation of the hERG-mediated cardiotoxicity risk of potential drug components.

E V Radchenko1,2, Yu A Rulev3, A Ya Safanyaev3, V A Palyulin3,4, N S Zefirov3,4.   

Abstract

The hERG potassium channel is one of the most important anti-targets determining cardiotoxicity of potential drugs. Using fragmental descriptors and artificial neural networks, the predictive models of the relationship between the structure of organic compounds and their activity with respect to hERG were built, and the structural factors affecting it were analyzed. By their predictive ability and applicability domain, these models (N = 1000, Q 2 = 0.77, RMSE cv = 0.45 for affinity and N = 2886, Q 2 = 0.60, RMSE cv = 0.55 for channel inhibition) are superior to the previously published models and can be used to minimize the risk of cardiotoxicity during drug development.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28510124     DOI: 10.1134/S1607672917020107

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  9 in total

1.  Fragmental approach in QSPR.

Authors:  Nikolai S Zefirov; Vladimir A Palyulin
Journal:  J Chem Inf Comput Sci       Date:  2002 Sep-Oct

2.  An approach to the interpretation of backpropagation neural network models in QSAR studies.

Authors:  I I Baskin; A O Ait; N M Halberstam; V A Palyulin; N S Zefirov
Journal:  SAR QSAR Environ Res       Date:  2002-03       Impact factor: 3.000

3.  Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data.

Authors:  Claire L Gavaghan; Catrin Hasselgren Arnby; Niklas Blomberg; Gert Strandlund; Scott Boyer
Journal:  J Comput Aided Mol Des       Date:  2007-03-24       Impact factor: 3.686

4.  Molecular design of selective ligands of chemokine receptors.

Authors:  M N Kurilo; F V Ryzhkov; P V Karpov; E V Radchenko; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2015-05-05       Impact factor: 0.788

Review 5.  In silico prediction of hERG inhibition.

Authors:  Yankang Jing; Alison Easter; David Peters; Norman Kim; Istvan J Enyedy
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 6.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

Review 7.  hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia.

Authors:  Hisashi Nogawa; Tomoyuki Kawai
Journal:  Eur J Pharmacol       Date:  2014-07-03       Impact factor: 4.432

8.  Experimentally validated HERG pharmacophore models as cardiotoxicity prediction tools.

Authors:  Jadel M Kratz; Daniela Schuster; Michael Edtbauer; Priyanka Saxena; Christina E Mair; Julia Kirchebner; Barbara Matuszczak; Igor Baburin; Steffen Hering; Judith M Rollinger
Journal:  J Chem Inf Model       Date:  2014-09-18       Impact factor: 6.162

9.  New potential binding determinant for hERG channel inhibitors.

Authors:  P Saxena; E-M Zangerl-Plessl; T Linder; A Windisch; A Hohaus; E Timin; S Hering; A Stary-Weinzinger
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.996

  9 in total
  7 in total

1.  Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity.

Authors:  Dmitry S Karlov; Nadezhda S Temnyakova; Dmitry A Vasilenko; Oleg I Barygin; Mikhail Y Dron; Arseniy S Zhigulin; Elena B Averina; Yuri K Grishin; Vladimir V Grigoriev; Alexey V Gabrel'yan; Viktor A Aniol; Natalia V Gulyaeva; Sergey V Osipenko; Yury I Kostyukevich; Vladimir A Palyulin; Petr A Popov; Maxim V Fedorov
Journal:  RSC Med Chem       Date:  2022-06-22

2.  Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies.

Authors:  Vladimir P Berishvili; Alexander N Kuimov; Andrew E Voronkov; Eugene V Radchenko; Pradeep Kumar; Yahya E Choonara; Viness Pillay; Ahmed Kamal; Vladimir A Palyulin
Journal:  Molecules       Date:  2020-07-11       Impact factor: 4.411

3.  Towards Deep Neural Network Models for the Prediction of the Blood-Brain Barrier Permeability for Diverse Organic Compounds.

Authors:  Eugene V Radchenko; Alina S Dyabina; Vladimir A Palyulin
Journal:  Molecules       Date:  2020-12-13       Impact factor: 4.411

4.  New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer's Disease Treatment.

Authors:  Galina F Makhaeva; Nadezhda V Kovaleva; Elena V Rudakova; Natalia P Boltneva; Sofya V Lushchekina; Irina I Faingold; Darya A Poletaeva; Yuliya V Soldatova; Raisa A Kotelnikova; Igor V Serkov; Anatoly K Ustinov; Alexey N Proshin; Eugene V Radchenko; Vladimir A Palyulin; Rudy J Richardson
Journal:  Molecules       Date:  2020-12-12       Impact factor: 4.411

5.  Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.

Authors:  Galina F Makhaeva; Nadezhda V Kovaleva; Natalia P Boltneva; Elena V Rudakova; Sofya V Lushchekina; Tatiana Yu Astakhova; Igor V Serkov; Alexey N Proshin; Eugene V Radchenko; Vladimir A Palyulin; Jan Korabecny; Ondrej Soukup; Sergey O Bachurin; Rudy J Richardson
Journal:  Molecules       Date:  2022-02-04       Impact factor: 4.411

Review 6.  KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity.

Authors:  Magdalena Kowalska; Jacek Nowaczyk; Alicja Nowaczyk
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

7.  New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment.

Authors:  Galina F Makhaeva; Nadezhda V Kovaleva; Natalia P Boltneva; Sofya V Lushchekina; Tatiana Yu Astakhova; Elena V Rudakova; Alexey N Proshin; Igor V Serkov; Eugene V Radchenko; Vladimir A Palyulin; Sergey O Bachurin; Rudy J Richardson
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.